As Recipharm continues to refine its footprint, the CDMO is selling its development and small-scale active pharmaceutical ingredient (API) manufacturing facility in Yavne, Israel, to Scinai ...
Fourth quarter earnings season is entering its final stretch. As of Feb. 13, 74% of S&P 500 (^GSPC) companies had reported results, according to FactSet data, and blended earnings growth — meaning a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results